Related Experiment Videos
Adverse drug reactions: reporting and evaluating cutaneous reactions
1Department of Dermatology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts.
Advances in Dermatology
|January 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.
The British journal of dermatology·2021
Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
The British journal of dermatology·2019
Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
Journal of the European Academy of Dermatology and Venereology : JEADV·2017
National registries of systemic treatment for psoriasis and the European 'Psonet' initiative.
Dermatology (Basel, Switzerland)·2008
A systematic review of the safety of topical therapies for atopic dermatitis.
The British journal of dermatology·2007
Uncommon benign infantile vascular tumors.
Advances in dermatology·2009
Cutaneous mosaicism: a molecular and clinical review.
Advances in dermatology·2009
Recent advances in acne vulgaris research: insights and clinical implications.
Advances in dermatology·2009
Update on the natural history and systemic treatment of psoriasis.
Advances in dermatology·2009
Management of childhood psoriasis.
Advances in dermatology·2009
Toll-like receptors in skin.
Advances in dermatology·2009
Novel Benzofuran Derivatives as SARM1 Inhibitors for Treating Axonal Degeneration.
ACS medicinal chemistry letters·2026
Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer.
ACS medicinal chemistry letters·2026
Structure-Activity Relationship Studies Resulting in the Identification of Potent and Selective Salt-Inducible Kinase Inhibitors.
ACS medicinal chemistry letters·2026
Structural Preferences and ADMET Regulation of Fluorinated Small-Molecule Drugs.
ACS medicinal chemistry letters·2026